Initial preclinical evaluation of 68Ga-DOTA-(Ser)3-LTVSPWY peptide as a PET radiotracer for glioblastoma targeting and imaging

aDepartment of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences

bDepartment of Radiology and Nuclear Medicine, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari

cMedical Nanotechnology & Tissue Engineering Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd

dResearch Center for Nuclear Medicine, Tehran University of Medical Sciences

eKhatam PET/CT Center, Specialty and Subspecialty Hospital of Khatam ol-Anbia, Tehran, Iran

Received 26 February 2022 Accepted 9 May 2022

Correspondence to Seyed Jalal Hosseinimehr, PhD, Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran, Tel/fax:+98 11 33544308; e-mail: [email protected]

留言 (0)

沒有登入
gif